A Case of Heart Failure in a Patient With Systemic Lupus Erythematosus.
AVB, atrioventricular block
BNP, B-type natriuretic peptide
ECG, electrocardiogram
EF, ejection fraction
EMB, endomyocardial biopsy
HCQ, hydroxychloroquine
SLE, systemic lupus erythematosus
cardiomyopathy
heart failure
hsTnI, high-sensitivity troponin I
hydroxychloroquine
systemic lupus erythematosus
Journal
JACC. Case reports
ISSN: 2666-0849
Titre abrégé: JACC Case Rep
Pays: Netherlands
ID NLM: 101757292
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
29
11
2019
accepted:
26
12
2019
entrez:
28
7
2021
pubmed:
18
3
2020
medline:
18
3
2020
Statut:
epublish
Résumé
Patients with systemic lupus erythematosus (SLE) can present with multiple cardiovascular pathologies, including pulmonary hypertension, valvular disease, pericarditis, myocarditis, and premature atherosclerosis. SLE medications can also cause cardiovascular side effects. We present a patient who developed a severe cardiomyopathy secondary to the hydroxychloroquine prescribed to treat her SLE. (
Identifiants
pubmed: 34317253
doi: 10.1016/j.jaccas.2019.12.040
pii: S2666-0849(20)30043-7
pmc: PMC8311708
doi:
Types de publication
Case Reports
Langues
eng
Pagination
414-419Références
Drug Saf. 2018 Oct;41(10):919-931
pubmed: 29858838
Br Heart J. 1993 May;69(5):451-2
pubmed: 8518071
Eur Heart J Acute Cardiovasc Care. 2013 Mar;2(1):77-83
pubmed: 24062937
N Engl J Med. 2011 Apr 14;364(15):1450-60
pubmed: 21488768
Immunopharmacol Immunotoxicol. 2013 Jun;35(3):434-42
pubmed: 23635029
J Mol Med (Berl). 1995 Feb;73(2):73-7
pubmed: 7627632